ErbB targeting inhibitors repress cell migration of esophageal squamous cell carcinoma and adenocarcinoma cells by distinct signaling pathways
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ErbB targeting inhibitors repress cell migration of esophageal squamous cell carcinoma and adenocarcinoma cells by distinct signaling pathways
Authors
Keywords
Esophageal cancer, ErbB, TKI, Migration, RhoA, STATs, FAK
Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 92, Issue 11, Pages 1209-1223
Publisher
Springer Nature
Online
2014-08-05
DOI
10.1007/s00109-014-1187-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging tyrosine kinase inhibitors for esophageal cancer
- (2013) Geoffrey Y Ku et al. EXPERT OPINION ON EMERGING DRUGS
- Oesophageal carcinoma
- (2013) Arjun Pennathur et al. LANCET
- Involvement of epidermal growth factor receptor overexpression in the promotion of breast cancer brain metastasis
- (2012) Fang Nie et al. CANCER
- Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal Adenocarcinomas
- (2012) H. H. Yoon et al. CLINICAL CANCER RESEARCH
- Toxin-induced RhoA Activity Mediates CCL1-triggered Signal Transducers and Activators of Transcription Protein Signaling
- (2012) Simone Reipschläger et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EGFR Inhibition in Glioma Cells Modulates Rho Signaling to Inhibit Cell Motility and Invasion and Cooperates with Temozolomide to Reduce Cell Growth
- (2012) Guillem Ramis et al. PLoS One
- Prognosis of Esophageal Squamous Cell Carcinoma in Patients Positive for Human Epidermal Growth Factor Receptor Family Can Be Improved by Initial Chemotherapy with Docetaxel, Fluorouracil, and Cisplatin
- (2011) Yota Yamamoto et al. ANNALS OF SURGICAL ONCOLOGY
- Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells
- (2011) Christiane D Fichter et al. BMC CELL BIOLOGY
- The R(h)oads to Stat3: Stat3 activation by the Rho GTPases
- (2011) Leda Raptis et al. EXPERIMENTAL CELL RESEARCH
- Lapatinib inhibits receptor phosphorylation and cell growth and enhances antibody-dependent cellular cytotoxicity of EGFR- and HER2-overexpressing esophageal cancer cell lines
- (2011) Kousaku Mimura et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting the human EGFR family in esophagogastric cancer
- (2011) Alicia Okines et al. Nature Reviews Clinical Oncology
- A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus
- (2010) David H. Ilson et al. CANCER
- Epidermal Growth Factor Stimulates Human Trophoblast Cell Migration through Rho A and Rho C Activation
- (2010) Jian Han et al. ENDOCRINOLOGY
- Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions
- (2010) M. D. Schaller JOURNAL OF CELL SCIENCE
- Convergence between Wnt-β-catenin and EGFR signaling in cancer
- (2010) Tianhui Hu et al. Molecular Cancer
- Cell adhesion: integrating cytoskeletal dynamics and cellular tension
- (2010) J. Thomas Parsons et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Delta-Crystallin Enhancer Binding Factor 1 Controls the Epithelial to Mesenchymal Transition Phenotype and Resistance to the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Human Head and Neck Squamous Cell Carcinoma Lines
- (2009) Y. Haddad et al. CLINICAL CANCER RESEARCH
- Focal adhesion kinase: switching between GAPs and GEFs in the regulation of cell motility
- (2009) Alok Tomar et al. CURRENT OPINION IN CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search